NARDONE, OLGA MARIA
 Distribuzione geografica
Continente #
AS - Asia 3.501
NA - Nord America 2.186
EU - Europa 1.756
SA - Sud America 362
AF - Africa 88
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.904
Nazione #
US - Stati Uniti d'America 2.082
SG - Singapore 1.567
RU - Federazione Russa 852
CN - Cina 774
VN - Vietnam 562
IT - Italia 370
BR - Brasile 291
HK - Hong Kong 242
FR - Francia 104
DE - Germania 100
NL - Olanda 88
KR - Corea 68
CA - Canada 59
GB - Regno Unito 58
IN - India 57
BD - Bangladesh 53
JP - Giappone 50
FI - Finlandia 40
MX - Messico 26
AR - Argentina 25
PL - Polonia 25
IE - Irlanda 24
ZA - Sudafrica 24
CI - Costa d'Avorio 18
TH - Thailandia 17
ID - Indonesia 15
PH - Filippine 13
RO - Romania 13
TR - Turchia 13
BG - Bulgaria 12
CO - Colombia 12
UA - Ucraina 12
EC - Ecuador 11
IQ - Iraq 11
UZ - Uzbekistan 11
VE - Venezuela 10
ES - Italia 9
MA - Marocco 9
AT - Austria 8
EG - Egitto 8
SE - Svezia 8
PK - Pakistan 7
KE - Kenya 6
KZ - Kazakistan 6
MY - Malesia 6
AU - Australia 5
BO - Bolivia 5
AL - Albania 4
DZ - Algeria 4
LT - Lituania 4
NG - Nigeria 4
PE - Perù 4
SA - Arabia Saudita 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
CH - Svizzera 2
CL - Cile 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
KW - Kuwait 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
NE - Niger 1
Totale 7.894
Città #
Singapore 784
San Jose 425
Hefei 342
Hong Kong 234
Moscow 224
Ashburn 184
Chandler 164
Beijing 159
Ho Chi Minh City 159
Hanoi 140
Naples 108
The Dalles 107
Santa Clara 94
Los Angeles 69
Lauterbourg 68
Seoul 63
Amsterdam 51
New York 47
Tokyo 43
Council Bluffs 37
Buffalo 33
Redondo Beach 30
Haiphong 27
Munich 27
Millbury 26
Napoli 26
Dallas 25
São Paulo 24
Frankfurt am Main 23
Da Nang 22
Helsinki 19
Boston 18
Warsaw 18
Chicago 17
Milan 17
Montreal 17
Seattle 17
Toronto 17
Des Moines 15
Nanjing 15
Orem 15
Rome 15
Boardman 14
Johannesburg 12
Sofia 12
Princeton 11
Kochi 10
Lawrence 10
Mexico City 10
Nuremberg 10
Redwood City 10
Tashkent 10
Atlanta 9
Can Tho 9
Dublin 9
London 9
Bangkok 8
Brooklyn 8
Düsseldorf 8
New Delhi 8
Phoenix 8
Rio de Janeiro 8
Wilmington 8
Denver 7
Jiaxing 7
Ottawa 7
Rochdale 7
Thái Bình 7
Thái Nguyên 7
Turku 7
Ankara 6
Bogotá 6
Bucharest 6
Elk Grove Village 6
Hải Dương 6
Kronberg 6
Nairobi 6
Quito 6
San Francisco 6
Vienna 6
Belo Horizonte 5
Bexley 5
Bắc Ninh 5
Catania 5
Charlotte 5
Chennai 5
Lappeenranta 5
Manchester 5
Ninh Bình 5
Wroclaw 5
Boydton 4
Clifton 4
Dhaka 4
Dong Ket 4
Falkenstein 4
Falls Church 4
Hangzhou 4
Houston 4
Jacksonville 4
Kuala Lumpur 4
Totale 4.365
Nome #
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with biologics 168
Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents 162
Bowel damage in Crohn's disease: direct comparison of ultrasonography- and magnetic resonance-based Lemann index. 160
Successful outcome of the transitional process of inflammatory bowel disease from pediatric to adult age: A five years experience 160
Bowel Damage in Crohn's Disease: Direct Comparison of Ultrasonography-based and Magnetic Resonance-based Lemann Index 158
Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn's Disease Patients Undergoing Multidetector CT-Enterography 153
Adherence in ulcerative colitis: an overview 150
Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease 149
Psoriasis Features in Patients with Inflammatory Bowel Disease 149
Different profile of efficacy of thiopurines in ulcerative colitis and Crohn's disease 148
Diagnostic Accuracy of Ultrasonography in the Detection of Postsurgical Recurrence in Crohn's Disease: A Systematic Review with Meta-analysis 147
Gut microbiota and Crohn's disease 146
Multi-detector CT enterography in active inflammatory bowel disease: Image quality and diagnostic efficacy of a low-radiation high contrast protocol 145
Efficacy of a "contact center-based communication" in optimizing the care of inflammatory bowel diseases 142
The burden of anaemia in patients with inflammatory bowel diseases 139
The metabolic role of gut microbiota in the development of nonalcoholic fatty liver disease and cardiovascular disease 134
Exclusive Enteral Nutrition in Adult Crohn’s Disease: an Overview of Clinical Practice and Perceived Barriers 131
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives 130
Probiotics in Gastrointestinal Diseases: All that Glitters Is Not Gold 128
Exploring the concept of deep remission in Crohn's disease: correlation between transmural healing and biomarkers 128
One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing. 128
Combined endoscopic/sonographic-based risk matrix model for predicting one-year risk of surgery: A prospective observational study of a tertiary centre severe/refractory crohn's disease cohort 127
The impact of a dedicated contact centre on the clinical outcome of patients with inflammatory bowel disease during the COVID-19 outbreak 126
Time to grow up: readiness associated with improved clinical outcomes in pediatric inflammatory bowel disease patients undergoing transition 123
Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life 121
Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study 120
Effectiveness of Partial Enteral Nutrition as Add-On to Biologics in Patients With Refractory and Difficult-to-Treat Crohn’s Disease: A Pilot Study 117
Gut microbiota and irritable bowel syndrome 117
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection 115
Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis 114
Italian validation of the IBD-disk tool for the assessment of disability in inflammatory bowel diseases: A cross-sectional multicenter study 112
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 110
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 109
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 108
Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era 102
Can a transition clinic bridge the gap between paediatric and adult inflammatory bowel disease care models? 101
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis 100
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's Disease 100
Insights into disability and psycho-social care of patients with inflammatory bowel disease 97
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting. 96
The Impact of Intestinal Ultrasound on the Management of Inflammatory Bowel Disease: From Established Facts Toward New Horizons 94
Rates of Endoscopic Recurrence In Postoperative Crohn's Disease Based on Anastomotic Techniques: A Systematic Review And Meta-Analysis 92
Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study 90
Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease 89
Objective comparison of vedolizumab and ustekinumab effectiveness in Crohn's disease patients failure to TNF-alpha inhibitors 86
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials 81
Inflammation-Driven Colorectal Cancer Associated with Colitis: From Pathogenesis to Changing Therapy 76
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis 73
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national survey 71
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 69
New endoscopic tools in inflammatory bowel disease 67
Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis 67
Advancing perioperative optimization in Crohn's disease surgery with machine learning predictions 66
Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study 64
Image-Enhanced Endoscopy Surveillance of Colon and Pouch Dysplasia in IBD 61
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis 60
Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video) 60
Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease? 59
Small molecule oral targeted therapies in ulcerative colitis 58
Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab 58
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?-Author's reply 56
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 55
Endocytoscopy with automated multispectral intestinal barrier pathology imaging for assessment of deep healing to predict outcomes in ulcerative colitis 55
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis 54
Key challenges and care approaches in inflammatory pouch disorders: What can we do better? 54
Addressing unmet needs of gastroenterologists' training in the post-COVID-19 era 53
Heterogeneity of definition of upper gastrointestinal tract in different guidelines of Crohn's disease: A scoping review 53
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 53
Insights into Probiotic Prescription among Gastroenterologists and Other Healthcare Professionals: Evidence from an Italian Survey 52
MMX mesalamine: A modern twist on a classic treatment 51
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 51
Image-Enhanced Endoscopy in the Surveillance of Colitis-Associated Neoplasia 50
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative 49
Clinical outcomes, predictors of prognosis and health economics consequences in IBD patients after discontinuation of the first biological therapy 46
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year 46
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 46
Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease 45
Venous and arterial thromboembolism in out-patients with inflammatory bowel disease: a single center study. 44
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission 44
Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research 43
Fecal Calprotectin Thresholds to Predict Endoscopic Remission Using Advanced Optical Enhancement Techniques and Histological Remission in IBD Patients 43
AI and endoscopy/histology in UC: the rise of machine 43
Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey 42
Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease 39
Reducing diagnostic delays of extraintestinal manifestations in inflammatory bowel disease: a comparative study of a multidisciplinary outpatient clinic versus conventional referral specialists 38
Digital biomarkers and artificial intelligence: a new frontier in personalized management of inflammatory bowel disease 23
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey 14
Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring 13
Artificial Intelligence in Advancing Inflammatory Bowel Disease Management: Setting New Standards 12
The role of fecal calprotectin in assessing response to advanced medical treatments for inflammatory bowel diseases: a review of the literature 12
Unveiling the effectiveness of Chat-GPT 4.0, an artificial intelligence conversational tool, for addressing common patient queries in gastrointestinal endoscopy 11
Global perspectives on sustainable IBD care 11
Inflammatory Bowel Diseases and Nephropathies: Exploring the Gut–Kidney Axis 11
Bowel Urgency Improvement Correlates With Clinical, Biochemical, and Intestinal Ultrasound Improvements in Inflammatory Bowel Disease: A Cross Sectional Multicenter Study 10
Advanced diagnostic and resection endoscopic techniques in managing colitis-associated neoplasia: standard of care or still utopia? 10
Comparative analysis of sporadic, IBD-associated, early-onset and late-onset colorectal cancer: a systematic review and meta-analysis 9
The Impact of E-Cigarettes and Heat-Not-Burn Tobacco on Postoperative Recurrence of Crohn's Disease: A Multicenter International Study 9
Prevalence of disability in inflammatory bowel disease: a systematic review and meta-analysis 9
Advancing Inflammatory Bowel Disease-Driven Colorectal Cancer Management: Molecular Insights and Endoscopic Breakthroughs Towards Precision Medicine 8
Attaining sustainability in inflammatory bowel disease 8
Totale 7.986
Categoria #
all - tutte 23.618
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.618


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 3 7
2021/2022183 0 0 2 2 1 2 0 9 12 12 52 91
2022/2023333 30 44 6 29 43 38 3 30 42 46 15 7
2023/2024335 7 35 15 15 10 28 62 45 6 5 69 38
2024/20252.152 108 101 6 16 65 108 266 124 125 242 778 213
2025/20264.789 459 534 565 460 661 175 496 263 673 321 182 0
Totale 8.060